Literature DB >> 28960868

Mimicking Intermolecular Interactions of Tight Protein-Protein Complexes for Small-Molecule Antagonists.

David Xu1,2, Khuchtumur Bum-Erdene3, Yubing Si1, Donghui Zhou3, Mona K Ghozayel3, Samy O Meroueh3,1.   

Abstract

Tight protein-protein interactions (Kd <100 nm) that occur over a large binding interface (>1000 Å2 ) are highly challenging to disrupt with small molecules. Historically, the design of small molecules to inhibit protein-protein interactions has focused on mimicking the position of interface protein ligand side chains. Here, we explore mimicry of the pairwise intermolecular interactions of the native protein ligand with residues of the protein receptor to enrich commercial libraries for small-molecule inhibitors of tight protein-protein interactions. We use the high-affinity interaction (Kd =1 nm) between the urokinase receptor (uPAR) and its ligand urokinase (uPA) to test our methods. We introduce three methods for rank-ordering small molecules docked to uPAR: 1) a new fingerprint approach that represents uPA's pairwise interaction energies with uPAR residues; 2) a pharmacophore approach to identify small molecules that mimic the position of uPA interface residues; and 3) a combined fingerprint and pharmacophore approach. Our work led to small molecules with novel chemotypes that inhibited a tight uPARuPA protein-protein interaction with single-digit micromolar IC50 values. We also report the extensive work that identified several of the hits as either lacking stability, thiol reactive, or redox active. This work suggests that mimicking the binding profile of the native ligand and the position of interface residues can be an effective strategy to enrich commercial libraries for small-molecule inhibitors of tight protein-protein interactions.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  protein-protein interactions; small molecules; urokinase receptor; virtual screening

Mesh:

Substances:

Year:  2017        PMID: 28960868      PMCID: PMC6067920          DOI: 10.1002/cmdc.201700572

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  50 in total

1.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

Authors:  Holger Gohlke; Christina Kiel; David A Case
Journal:  J Mol Biol       Date:  2003-07-18       Impact factor: 5.469

2.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Authors:  Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

3.  PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results.

Authors:  Steven L Dixon; Alexander M Smondyrev; Eric H Knoll; Shashidhar N Rao; David E Shaw; Richard A Friesner
Journal:  J Comput Aided Mol Des       Date:  2006-11-24       Impact factor: 3.686

4.  Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface.

Authors:  Huameng Li; Hui Xiao; Li Lin; David Jou; Vandana Kumari; Jiayuh Lin; Chenglong Li
Journal:  J Med Chem       Date:  2014-01-31       Impact factor: 7.446

5.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

6.  Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening.

Authors:  Ka-Ho Leung; Li-Juan Liu; Sheng Lin; Lihua Lu; Hai-Jing Zhong; Dewi Susanti; Weidong Rao; Modi Wang; Weng Ian Che; Daniel Shiu-Hin Chan; Chung-Hang Leung; Philip Wai Hong Chan; Dik-Lung Ma
Journal:  Methods       Date:  2014-08-24       Impact factor: 3.608

Review 7.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

8.  Targeting multiple conformations leads to small molecule inhibitors of the uPAR·uPA protein-protein interaction that block cancer cell invasion.

Authors:  May Khanna; Fang Wang; Inha Jo; W Eric Knabe; Sarah M Wilson; Liwei Li; Khuchtumur Bum-Erdene; Jing Li; George W Sledge; Rajesh Khanna; Samy O Meroueh
Journal:  ACS Chem Biol       Date:  2011-09-29       Impact factor: 5.100

9.  Characterization of the functional epitope on the urokinase receptor. Complete alanine scanning mutagenesis supplemented by chemical cross-linking.

Authors:  Henrik Gårdsvoll; Bernard Gilquin; Marie Hélène Le Du; Andre Ménèz; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2006-05-03       Impact factor: 5.157

10.  Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environments.

Authors:  Karina M Soares; Nicole Blackmon; Tong Ying Shun; Sunita N Shinde; Harold K Takyi; Peter Wipf; John S Lazo; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-04       Impact factor: 1.738

View more
  7 in total

1.  Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond?

Authors:  Julie M Leth; Haydyn D T Mertens; Katrine Zinck Leth-Espensen; Thomas J D Jørgensen; Michael Ploug
Journal:  J Biol Chem       Date:  2019-03-20       Impact factor: 5.157

2.  Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries.

Authors:  Yubing Si; David Xu; Khuchtumur Bum-Erdene; Mona K Ghozayel; Baocheng Yang; Paul A Clemons; Samy O Meroueh
Journal:  ChemMedChem       Date:  2018-12-20       Impact factor: 3.466

3.  Unconventional Secondary Structure Mimics: Ladder-Rungs.

Authors:  Chen-Ming Lin; Maritess Arancillo; Jonathan Whisenant; Kevin Burgess
Journal:  Angew Chem Int Ed Engl       Date:  2020-04-20       Impact factor: 15.336

Review 4.  Therapeutic potential of targeting the Eph/ephrin signaling complex.

Authors:  Nayanendu Saha; Dorothea Robev; Emilia O Mason; Juha P Himanen; Dimitar B Nikolov
Journal:  Int J Biochem Cell Biol       Date:  2018-10-19       Impact factor: 5.085

5.  Design and Synthesis of Fragment Derivatives with a Unique Inhibition Mechanism of the uPAR·uPA Interaction.

Authors:  Khuchtumur Bum-Erdene; Degang Liu; David Xu; Mona K Ghozayel; Samy O Meroueh
Journal:  ACS Med Chem Lett       Date:  2020-12-10       Impact factor: 4.345

Review 6.  Evolution and Medical Significance of LU Domain-Containing Proteins.

Authors:  Julie Maja Leth; Katrine Zinck Leth-Espensen; Kristian Kølby Kristensen; Anni Kumari; Anne-Marie Lund Winther; Stephen G Young; Michael Ploug
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

Review 7.  Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.

Authors:  Bing-Tao Zhai; Huan Tian; Jing Sun; Jun-Bo Zou; Xiao-Fei Zhang; Jiang-Xue Cheng; Ya-Jun Shi; Yu Fan; Dong-Yan Guo
Journal:  J Transl Med       Date:  2022-03-18       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.